Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Oct 21, 2019
Date Accepted: Mar 20, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Radio vs. Facebook: Evaluating Two Common Strategies for Research-Participant Recruitment into Autism Studies
ABSTRACT
Background:
Ongoing research is necessary to better understand causes of and developmental outcomes for ASD, as well as the efficacy of interventions. However, studies often face difficulty recruiting a sufficient number of participants, and despite the prevalence of ASD, little research has focused on how to efficiently recruit participants with autism.
Objective:
We were interested in determining the efficacy of two different paid advertisements for a study enrolling people with ASD and their family members: social media and radio advertising.
Methods:
Using enrollment numbers and data from a post-enrollment survey, we examined participant enrollment on three parameters: number of participants enrolled, cost per participant, and geographic reach.
Results:
Social media advertising outperformed radio on all three parameters examined by enrolling more participants (338 vs. 149), with a lower cost per participant ($8.73 vs. $80.74), and a wider geographic reach (χ2 (1, N = 367) = 5.85, p = .02).
Conclusions:
Findings suggest that advertising on social media can efficiently reach a large pool of potential participants with ASD, increasing the likelihood of meeting study enrollment goals.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.